×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| SANJIVANI PARANTERAL LTD. | 176.61 | 18.98 | 173.49 | 1.62 | 323.0 | 45.1 |
| Fredun Pharmaceuticals Limited | 1,026.97 | 53.33 | 1,018.41 | 11.29 | 322 | 17.1 |
| GENNEX LABORATORIES LTD. | 400.06 | 50.65 | 377.07 | 0.22 | 321 | 17.2 |
Sanjivani Paranteral Ltd., with Security Code 531569, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.9 | 8.3 | 9.1 | 8.1 | 12.5 | 14.0 | 14.9 | 12.8 | 16.4 | 18.1 |
| Expenses | 7.8 | 7.2 | 8.2 | 6.7 | 10.6 | 11.9 | 13.0 | 10.7 | 14.1 | 15.3 |
| Operating Profit | 2.2 | 1.1 | 0.9 | 1.4 | 2.0 | 2.1 | 2.0 | 2.2 | 2.3 | 2.9 |
| OPM % | 21.76% | 13.6% | 10.12% | 17.56% | 15.99% | 15.1% | 13.09% | 16.78% | 14.22% | 15.74% |
| Other Income | 0.1 | 0.2 | 0.3 | 0.0 | 0.1 | 0.2 | 0.3 | 0.1 | 0.1 | 0.4 |
| Interest | 0.1 | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.2 |
| Depreciation | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 |
| Profit before tax | 2.0 | 1.0 | 1.0 | 1.0 | 1.8 | 2.0 | 1.9 | 1.9 | 2.3 | 2.9 |
| Tax % | 9.4% | 24.2% | 0% | 0.1% | 13.9% | 14.1% | 13.2% | 33.2% | 24.6% | 21.3% |
| Net Profit | 1.8 | 0.8 | 1.0 | 1.0 | 1.6 | 1.7 | 1.7 | 1.3 | 1.7 | 2.3 |
| EPS in Rs | 1.8 | 0.76 | 0.95 | 1 | 1.55 | 1.71 | 1.65 | 1.08 | 1.47 | 1.96 |
| Metrics | Sep 2024 | Dec 2024 |
|---|---|---|
| Sales | 18.1 | 17.3 |
| Expenses | 15.3 | 14.8 |
| Operating Profit | 2.9 | 2.5 |
| OPM % | 15.7% | 14.7% |
| Other Income | 0.4 | 0.3 |
| Interest | 0.2 | 0.2 |
| Depreciation | 0.1 | 0.2 |
| Profit before tax | 2.9 | 2.5 |
| Tax % | 21.3% | 24.4% |
| Net Profit | 2.3 | 1.9 |
| EPS in Rs | 1 | 1 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | 19% |
| 3 Years: | 33% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 38% |
| 3 Years: | 63% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 99% |
| 3 Years: | 70% |
| 1 Year: | 55% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 99% |
| 3 Years: | 70% |
| 1 Year: | 55% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|